Thu, Jul 24, 2014, 10:27 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Affymax, Inc. (AFFY) Message Board

  • dr.noshots dr.noshots Jul 5, 2013 10:06 AM Flag


    They all have problems but continue to exist:

    Use Of Triptans Contraindicated In 5 Million Americans.
    Medscape (7/3, Anderson) reported that nearly “five million Americans with episodic migraine (EM) should not be prescribed a triptan... because of the presence of cardiovascular contraindications,” according to a study presented at the International Headache Congress. Study co-investigator Dawn Buse, PhD, associate professor of neurology at the Albert Einstein College of Medicine in New York, said the results “highlight an area of unmet need for acute migraine treatment without cardiovascular risk and contraindications,” which as the senior population grows, older migraine patients “with cardiovascular events, conditions, and procedures will likely increase, and the resulting unmet need will increase.”

    Sentiment: Strong Buy

0.1005+0.0005(+0.50%)Jul 24 3:52 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.